Replacement of bone marrow by bone in rat femurs: The bone bioreactor

Tissue Engineering - Part A.

Volumn 14, Issue 2, 2008, Pages 237-246

  Zhang, Qing ^a   Cuartas, Esteban ^a   Mehta, Nozer ^b   Gilligan, James ^b   Ke, Hua Zhu ^c   Saltzman, W Mark ^d   Kotas, Maya ^d   Ma, Mandy ^d   Rajan, Sonali ^d   Chalouni, Cécile ^a   Carlson, Jodi ^a   Vignery, Agnès ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Unigene Laboratories Incorporated   (United States)

^c PFIZER INC   (United States)

^d Yale University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; BIOREACTORS; COMPUTERIZED TOMOGRAPHY; HORMONES; OSTEOBLASTS; RATS; ABLATION; AMINES; BODY FLUIDS; CALCIUM; CALCIUM ALLOYS; CONCENTRATION (PROCESS); DIAGNOSTIC RADIOGRAPHY; EXPERIMENTS; HEALTH; IMAGING TECHNIQUES; MEDICAL IMAGING; THERMOGRAPHY (TEMPERATURE MEASUREMENT); TISSUE ENGINEERING; TOMOGRAPHY; VEHICLES;

BONE BIOREACTORS; BONE MARROW; FEMURS; MARROW ABLATION; MARROW CAVITY; BIO REACTOR; BIOMECHANICAL PROPERTIES; BIOMECHANICAL TESTING; BONE FORMATION; BONE GROWTH; BONE LOSS; BONE MARROW (BM); COMPUTED TOMOGRAPHY (CT); CONCENTRATION (COMPOSITION); HISTOLOGICAL ANALYSIS; MICRO SCALES; OSTEOCALCIN (OC); PARATHYROID HORMONE (PTH); PERIPHERAL (SPI); QUANTITATIVE COMPUTED TOMOGRAPHY (QCT); RECEPTOR ACTIVATOR; REGENERATIVE MEDICINES; SERUM CONCENTRATIONS; SOFT X RAY (SXR); TARTRATE-RESISTANT ACID PHOSPHATASE (TRAP); TRANSIENT FORMATION;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCIUM; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE RELATED PROTEIN; RECOMBINANT PARATHYROID HORMONE; ACID PHOSPHATASE; ISOENZYME; PARATHYROID HORMONE; TARTRATE-RESISTANT ACID PHOSPHATASE; ANABOLIC AGENT; PARATHYROID HORMONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE MARROW; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG MECHANISM; FEMUR; FEMUR SHAFT; HISTOPATHOLOGY; MALE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; ANIMAL; BIOREACTOR; BLOOD; BONE; BONE DEVELOPMENT; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; METHODOLOGY; TISSUE ENGINEERING; ANIMAL CELL; ANIMAL TISSUE; BONE DENSITY; BONE GROWTH; BONE MARROW RESCUE; BONE REMODELING; CALCIUM BLOOD LEVEL; HISTOLOGY; OSTEOLYSIS; PROTEIN BLOOD LEVEL; REGENERATIVE MEDICINE; SHAM PROCEDURE; TRABECULAR BONE; TREATMENT DURATION; X RAY ANALYSIS;

ANIMALIA; RATTUS;

ACID PHOSPHATASE; ANIMALS; BIOREACTORS; BONE AND BONES; BONE DEVELOPMENT; BONE MARROW; CALCIUM; FEMUR; HUMANS; ISOENZYMES; MALE; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; RANK LIGAND; RATS; TISSUE ENGINEERING;

EID: 39449102655     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/tea.2007.0261     Document Type: Article

References (27)

1. Amsel, S., Maniatis, A., Tavassoli, M., and Crosby, W.H. The significance of intramedullary cancellous bone formation in the repair of bone marrow tissue. Anat Rec 164, 101-111, 1969.
2. Patt, H.M., and Maloney, M.A. Bone marrow regeneration after local injury: a review. Exp Hematol 3, 135-148, 1975.
3. Bab, I., Gazit, D., Muhlrad, A., and Shteyer, A. Regenerating bone marrow produces a potent growth-promoting activity to osteogenic cells. Endocrinology 123, 345-352, 1988. Erratum in: Endocrinology 128, 2638, 1991.
4. Suva, L.J., Seedor, J.G., Endo, N., Quartuccio, H.A., Thompson, D.D., Bab, I., and Rodan, G.A. Pattern of gene expression following tibial marrow ablation. J Bone Mineral Res 8, 379-388, 1993.
5. Shimizu, T., Mehdi, R., Yoshimura, Y., Yoshikawa, H., Nomura, S., Miyazono, K., and Takaoka, K. Sequential expression of bone morphogenetic protein, tumor necrosis factor, and their receptors in bone-forming reaction after mouse femoral marrow ablation. Bone 23, 127-133, 1998.
6. Kuroda, S., Virdi, A.S., Dai, Y., Shott, S., and Sumner, D.R. Patterns and localization of gene expression during intramembranous bone regeneration in the rat femoral marrow ablation model. Calcif Tissue Int 77, 212-225, 2005. Epub 2005 Sep 28.
7. Yamashita, T., Yoshitake, H., Tsuji, K., Kawaguchi, N., Nabeshima, Y.-I., and Noda, M. Retardation in bone resorption after bone marrow ablation in Klotho mutant mice. Endocrinology 141, 438-445, 2000.
8. Chen, X.D., Allen, M.R., Bloomfield, S., Xu, T., and Young, M. Biglycan-deficient mice have delayed osteogenesis after marrow ablation. Calcif Tissue Int 72, 577-582, 2003.
9. Tsuji, K., Komori, T., and Noda, M. Aged mice require full transcription factor, Runx2/Cbfa1, gene dosage for cancellous bone regeneration after bone marrow ablation. J Bone Miner Res 19, 1481-1489, 2004.
10. Morinobu, M., Nakamoto, T., Hino, K., Tsuji, K., Shen, Z.J., Nakashima, K., Nifuji, A., Yamamoto, H., Hirai, H., and Noda, M. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. J Exp Med 201, 961-970, 2005.
11. Tanaka, H., Wakisaka, A., Ogasa, H., Kawai, S., and Liang, C.T. Local and systemic expression of insulin-like growth factor-I (IGF-I) mRNAs in rat after bone marrow ablation. Biochem Biophys Res Commun 287, 1157-1162, 2001.
12. Reeve, J., Hesp, R., Williams, D., Hulme, P., Klenerman, L., Zanelli, J.-M., Darby, A.J., Tregear, G.W., and Parsons, J.A. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet 1, 1035-1038, 1976.
13. Reeve, J., Meunier, P.J., Parsons, J.A., Bernat, M., Bijvoet, O.L., Courpron, P., Edouard, C., Klenerman, L., Neer, R.M., Renier, J.C., Slovik, D., Vismans, F.J., and Potts, J.T., Jr. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 280, 1340-1344, 1980.
14. Moseley, J.M., Kubota, M., Diefenbach-Jagger, H., Wettenhall, R.E., Kemp, B.E., Suva, L.J., Rodda, C.P., Ebeling, P.R., Hudson, P.J., Zajac, J.D., and Martin, T.J. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 84, 5048-5052, 1987.
15. Strewler, G.J., Stern, P.H., Jacobs, J.W., Eveloff, J., Klein, R.F., Leung, S.C., Rosenblatt, M., and Nissenson, R.A. Parathyroid hormone-like protein from human renal carcinoma cells: structural and functional homology with parathyroid hormone. J Clin Invest 80, 1803-1807, 1987.
16. Stewart, A.F., Wu, T., Goumas, D., Burtis, W.J., and Broadus, A.E. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem Biophys Res Commun 146, 672-678, 1987.
17. Horwitz, M.J., Tedesco, M.B., Gundberg, C., Garcia-Ocana, A., and Stewart, A.F. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 88, 569-575, 2003.
18. Ballica, R., Valentijn, K., Khachatryan, A., Guerder, S., Kapadia, S., Gundberg, C., Gilligan, J., Flavell, R.A., and Vignery, A. Targeted expression of calcitonin gene related peptide to osteoblasts increases bone density in mice. J Bone Miner Res 14, 1067-1074, 1999.
19. Li, H., Cuartas, E., Cui, W., Choi, Y., Crawford, D.T., Ke, H.Z., Kobayashi, K.S., Flavell, R.A., and Vignery, A. Interleukin-1-associated kinase M is a central regulator of osteoclast differentiation and activation. J Exp Med 201, 1169-1177, 2005.
20. Vignery, A., and Baron, R. Dynamic histomorphometry of alveolar bone remodeling in the adult rat. Anat Rec 196, 191-200, 1980.
21. Baron, R., Tross, R., and Vignery, A. Evidence of sequential remodeling histomorphometry during skeletal maturation. Anat Rec 208, 137-145, 1984.
22. Gundberg, C., Hauschka, P.V., Lian, J.B., and Gallop, P.M. Osteocalcin: isolation, characterization, and detection. Methods Enzymol 107, 516-544, 1984.
23. Martin, T.J., and Sims, N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11, 76-81, 2005.
24. Koh, A.J., Demiralp, B., Neiva, K.G., Hooten, J., Nohutcu, R.M., Shim, H., Datta, N.S., Taichman, R.S., and McCauley, L.K. Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. Endocrinology 146, 4584-4596, 2005.
25. Kieslinger, M., Folberth, S., Dobreva, G., Dorn, T., Croci, L., Erben, R., Consalez, G.G., and Grosschedl, R. EBF2 regulates osteoblast-dependent differentiation of osteoclasts. Dev Cell 6, 757-767, 2005.
26. Gabet, Y., Müller, R., Levy, J., Dimarchi, R., Chorev, M., Bab, I., and Kohavi, D. Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis. Bone 39, 276-282, 2006.
27. Miao, D., He, B., Jiang, Y., Kobayashi, T., Soroceanu, M.A., Zhao, J., Su, H., Tong, X., Amizuka, N., Gupta, A., Genant, H.K., Kronenberg, H.M., Goltzman, D., and Karaplis, A.C. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115, 2402-2411, 2005.